Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia

European Psychiatry

Volumn 25, Issue 6, 2010, Pages 314-319

  Voisey, J ^a   Swagell, C D ^a   Hughes, I P ^a   Lawford, B R ^a,b   Young, R M ^a   Morris, C P ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Dystrobrevin binding protein 1; Genetic association; Genetics; Glutamatergic pathway; Molecular biology; Polymorphism; Schizophrenia and psychosis

Indexed keywords

DYSBINDIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE MAP; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ALLELES; CARRIER PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SALIVA; SCHIZOPHRENIA; YOUNG ADULT;

EID: 77955097288     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.11.011     Document Type: Article

References (51)

1. Abramson J.H. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004, 1:6.
2. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995, 57:289-300. Series B.
3. Benson M.A., Newey S.E., Martin-Rendon E., Hawkes R., Blake D.J., Dysbindin a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 2001, 276:24232-24241.
4. Betcheva E.T., Mushiroda T., Takahashi A., Kubo M., Karachanak S.K., Zaharieva I.T., et al. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 2009, 54:98-107.
5. Bhardwaj S.K., Baharnoori M., Sharif-Askari B., Kamath A., Williams S., Srivastava L.K. Behavioral characterization of dysbindin-1 deficient sandy mice. Behav Brain Res 2009, 197:435-441.
6. Bray N.J., Preece A., Williams N.M., Moskvina V., Buckland P.R., Owen M.J., et al. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 2005, 14:1947-1954.
7. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999, 56:162-168.
8. Cox M.M., Tucker A.M., Tang J., Talbot K., Richer D.C., Yeh L., et al. Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. Genes Brain Behav 2009, 8:390-397.
9. Datta S.R., McQuillin A., Puri V., Choudhury K., Thirumalai S., Lawrence J., et al. Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia. Behav Brain Funct 2007, 3:50.
10. Duan J., Martinez M., Sanders A.R., Hou C., Burrell G.J., Krasner A.J., et al. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene. Hum Hered 2007, 64:97-106.
11. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 2005, 77:918-936.
12. Feng Y.Q., Zhou Z.Y., He X., Wang H., Guo X.L., Hao C.J., et al. Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia. Schizophr Res 2008, 106:218-228.
13. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
14. Funke B., Finn C.T., Plocik A.M., Lake S., DeRosse P., Kane J.M., et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 2004, 75:891-898.
15. Hattori S., Murotani T., Matsuzaki S., Ishizuka T., Kumamoto N., Takeda M., et al. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem Biophys Res Commun 2008, 373:298-302.
16. Holliday E.G., Handoko H.Y., James M.R., McGrath J.J., Nertney D.A., Tirupati S., et al. Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Res Hum Genet 2006, 9:531-539.
17. Iizuka Y., Sei Y., Weinberger D.R., Straub R.E. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J Neurosci 2007, 27:12390-12395.
18. Kirov G., Ivanov D., Williams N.M., Preece A., Nikolov I., Milev R., et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 2004, 55:971-975.
19. Lang U.E., Puls I., Muller D.J., Strutz-Seebohm N., Gallinat J. Molecular mechanisms of schizophrenia. Cell Physiol Biochem 2007, 20:687-702.
20. Li D., He L. Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis. Schizophr Res 2007, 96:112-118.
21. Li T., Zhang F., Liu X., Sun X., Sham P.C., Crombie C., et al. Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol Psychiatry 2005, 10:1037-1044.
22. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
23. Moises H.W., Yang L., Kristbjarnarson H., Wiese C., Byerley W., Macciardi F., et al. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995, 11:321-324.
24. Morris D.W., McGhee K.A., Schwaiger S., Scully P., Quinn J., Meagher D., et al. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr Res 2003, 60:167-172.
25. Mutsuddi M., Morris D.W., Waggoner S.G., Daly M.J., Scolnick E.M., Sklar P. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am J Hum Genet 2006, 79:903-909.
26. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., Suzuki T., Iwata N., et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 2004, 13:2699-2708.
27. Ott J. Utility programs for analysis of genetic linkage. Program. HWE version 1.10. New York: Columbia University; 1988.
28. Owen M.J., Williams N.M., O'Donovan M.C. Dysbindin-1 and schizophrenia: from genetics to neuropathology. J Clin Invest 2004, 113:1255-1257.
29. Pae C.U., Mandelli L., De Ronchi D., Kim J.J., Jun T.Y., Patkar A.A., et al. Dysbindin gene (DTNBP1) and schizophrenia in Korean population. Eur Arch Psychiatry Clin Neurosci 2009, 259:137-142.
30. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 2007;13(10):1264.
31. Peralta V., Cuesta M.J. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 1994, 53:31-40.
32. Peters K., Wiltshire S., Henders A.K., Dragovic M., Badcock J.C., Chandler D., et al. Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1159-1166.
33. Peters K., Wiltshire S., Henders A.K., Dragovic M., Badcock J.C., Chandler D., et al. Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes. Am J Med Genet 2008, 147B:1159-1166. Part B.
34. Riley B., Kendler K.S. Molecular genetic studies of schizophrenia. Eur J Hum Genet 2006, 14:669-680.
35. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008, 165:497-506.
36. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003, 72:185-190.
37. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002, 71:337-348.
38. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003, 60:1187-1192.
39. Takao K., Toyama K., Nakanishi K., Hattori S., Takamura H., Takeda M., et al. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol Brain 2008, 1:11.
40. Talbot K., Eidem W.L., Tinsley C.L., Benson M.A., Thompson E.W., Smith R.J., et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004, 113:1353-1363.
41. Tang J.X., Zhou J., Fan J.B., Li X.W., Shi Y.Y., Gu N.F., et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 2003, 8:717-718.
42. Tochigi M., Zhang X., Ohashi J., Hibino H., Otowa T., Rogers M., et al. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res 2006, 56:154-158.
43. Tosato S., Ruggeri M., Bonetto C., Bertani M., Marrella G., Lasalvia A., et al. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:647-659.
44. Van Den Bogaert A., Schumacher J., Schulze T.G., Otte A.C., Ohlraun S., Kovalenko S., et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 2003, 73:1438-1443.
45. van den Oord E.J., Sullivan P.F., Jiang Y., Walsh D., O'Neill F.A., Kendler K.S., et al. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol Psychiatry 2003, 8:499-510.
46. Vilella E., Costas J., Sanjuan J., Guitart M., De Diego Y., Carracedo A., et al. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res 2008, 42:278-288.
47. Wang S., Sun C.E., Walczak C.A., Ziegle J.S., Kipps B.R., Goldin L.R., et al. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet 1995, 10:41-46.
48. Weickert C.S., Straub R.E., McClintock B.W., Matsumoto M., Hashimoto R., Hyde T.M., et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 2004, 61:544-555.
49. Weickert C.S., Rothmond D.A., Hyde T.M., Kleinman J.E., Straub R.E. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr Res 2008, 98:105-110.
50. Williams N.M., Preece A., Morris D.W., Spurlock G., Bray N.J., Stephens M., et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 2004, 61:336-344.
51. Wood L.S., Pickering E.H., Dechairo B.M. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol Psychiatry 2007, 61:1195-1199.